Results for tag: "Pancreatin"

Pancreatin is a type of pancreatic cancer drug used to treat the disease. It is a combination of enzymes that help break down proteins, fats, and carbohydrates in the body. Pancreatin is used to reduce the symptoms of pancreatic cancer, such as pain, nausea, and vomiting. It can also help reduce the size of tumors and improve the quality of life for those with the disease. Pancreatin is typically administered orally or intravenously, depending on the severity of the cancer. The pancreatin market is highly competitive, with many companies offering different formulations of the drug. Companies are constantly researching and developing new formulations to improve the efficacy of the drug. Additionally, companies are looking for ways to reduce the cost of the drug, making it more accessible to those who need it. Some of the companies in the pancreatin market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more